{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:49:36Z","timestamp":1787028576698,"version":"build-2736575974"},"reference-count":93,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Progressive pulmonary fibrosis (PPF) encompasses fibrosing interstitial lung diseases marked by relentless scarring of the lungs, leading to respiratory failure. Although its pathogenesis remains incompletely understood, recent genetic discoveries have shed light on the molecular mechanisms that drive PPF onset and progression. This comprehensive review summarizes current knowledge of PPF genetics, highlighting both rare pathogenic variants and more common susceptibility polymorphisms. Key genetic contributors include telomere maintenance genes, surfactant protein genes, and the MUC5B promoter variant rs35705950, which is the strongest known genetic risk factor for idiopathic pulmonary fibrosis. We also discuss epigenetic factors such as DNA methylation and histone modifications that regulate fibrotic gene expression. Integrating genetic findings with clinical phenotypes reveals distinct disease endotypes with different prognoses and therapeutic responses, laying the groundwork for precision medicine in PPF treatment. Finally, we address the clinical implications of PPF genetics, including advances in genetic testing, biomarker development, and emerging gene-targeted treatment strategies.<\/jats:p>","DOI":"10.3390\/ijms262411846","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T14:52:24Z","timestamp":1765205544000},"page":"11846","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Genetic Determinants of Progressive Pulmonary Fibrosis: A Comprehensive Review"],"prefix":"10.3390","volume":"26","author":[{"given":"Ardak","family":"Zhumagaliyeva","sequence":"first","affiliation":[{"name":"Department of Family Medicine No.2, Astana Medical University, Astana 010000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Chorostowska-Wynimko","sequence":"additional","affiliation":[{"name":"Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9814-0324","authenticated-orcid":false,"given":"Aleksandra","family":"Jezela-Stanek","sequence":"additional","affiliation":[{"name":"Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2103132","DOI":"10.1183\/13993003.03132-2021","article-title":"Genetic overlap between idiopathic pulmonary fibrosis and COVID-19","volume":"60","author":"Allen","year":"2022","journal-title":"Eur. Respir. J."},{"key":"ref_2","unstructured":"Froidure, A., W\u00e9meau-Stervinou, L., and Cottin, V. (2024). The genetics of pulmonary fibrosis: From rare to common variants. Hum. Genet."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Golchin, N., Patel, A., Scheuring, J., Wan, V., Hofer, K., Collet, J.-P., Elpers, B., and Lesperance, T. (2025). Incidence and prevalence of idiopathic pulmonary fibrosis: A systematic literature review and meta-analysis. BMC Pulm. Med., 25.","DOI":"10.1186\/s12890-025-03836-1"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMra2005230","article-title":"Spectrum of Fibrotic Lung Diseases","volume":"383","author":"Wijsenbeek","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12931-018-0730-2","article-title":"Idiopathic pulmonary fibrosis: Pathogenesis and management","volume":"19","author":"Sgalla","year":"2018","journal-title":"Respir. Res."},{"key":"ref_7","unstructured":"Pulmonary Fibrosis Foundation (2023). Genetic Testing in Pulmonary Fibrosis for Health Care Providers, Pulmonary Fibrosis Foundation."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.chest.2021.06.037","article-title":"Familial Pulmonary Fibrosis: Genetic Features and Clinical Implications","volume":"160","author":"Zhang","year":"2021","journal-title":"Chest"},{"key":"ref_9","unstructured":"Allen, R.J., Martinez, F.J., and Jenkins, R.G. (2025). Genome-wide association study of progressive fibrosing interstitial lung disease. medRxiv."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1164\/rccm.202401-0238SO","article-title":"Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine","volume":"210","author":"Adegunsoye","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa1013660","article-title":"A common MUC5B promoter polymorphism and pulmonary fibrosis","volume":"364","author":"Seibold","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/ng.3278","article-title":"Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening","volume":"47","author":"Stuart","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nrg3246","article-title":"The telomere syndromes","volume":"13","author":"Armanios","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMc1013504","article-title":"A variant in the promoter of MUC5B and idiopathic pulmonary fibrosis","volume":"364","author":"Zhang","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Alonso-Gonzalez, A., Tosco-Herrera, E., Molina-Molina, M., and Flores, C. (2023). Idiopathic pulmonary fibrosis and the role of genetics in the era of precision medicine. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1152211"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1001\/jama.2013.5827","article-title":"Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis","volume":"309","author":"Peljto","year":"2013","journal-title":"JAMA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12931-021-01694-z","article-title":"Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment","volume":"22","author":"Biondini","year":"2021","journal-title":"Respir. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.chest.2022.04.001","article-title":"MUC5B Promoter Polymorphism and Survival in Indian Patients With Idiopathic Pulmonary Fibrosis","volume":"162","author":"Dhooria","year":"2022","journal-title":"Chest"},{"key":"ref_19","first-page":"14953","article-title":"Association between MUC5B polymorphism and susceptibility and severity of idiopathic pulmonary fibrosis","volume":"8","author":"Jiang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S2213-2600(17)30387-9","article-title":"Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: A genome-wide association study","volume":"5","author":"Allen","year":"2017","journal-title":"Lancet Respir. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/ng.2609","article-title":"Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis","volume":"45","author":"Fingerlin","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/MCP.0000000000000989","article-title":"Recent advances in the genetics of idiopathic pulmonary fibrosis","volume":"29","author":"Kaur","year":"2023","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"17534666211042529","DOI":"10.1177\/17534666211042529","article-title":"DSP rs2076295 variants influence nintedanib and pirfenidone outcomes in idiopathic pulmonary fibrosis: A pilot study","volume":"15","author":"Doubkova","year":"2021","journal-title":"Ther. Adv. Respir. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13023-021-01750-3","article-title":"Potential clinical utility of MUC5B und TOLLIP single nucleotide polymorphisms (SNPs) in the management of patients with IPF","volume":"16","author":"Bonella","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1164\/rccm.201505-1010OC","article-title":"TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis","volume":"192","author":"Oldham","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1164\/rccm.202111-2590LE","article-title":"Toll-Interacting Protein and Altered Lung Microbiota in Idiopathic Pulmonary Fibrosis","volume":"206","author":"Lipinski","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e2279","DOI":"10.1002\/mgg3.2279","article-title":"Association of family sequence similarity gene 13A gene polymorphism and interstitial lung disease susceptibility: A systematic review and meta-analysis","volume":"11","author":"Hu","year":"2023","journal-title":"Mol. Genet. Genom. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1164\/rccm.201509-1863OC","article-title":"Desmoplakin Variants Are Associated with Idiopathic Pulmonary Fibrosis","volume":"193","author":"Mathai","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1164\/rccm.202203-0612ED","article-title":"Genetic Association Study Advances Idiopathic Pulmonary Fibrosis Pathophysiology and Health Equity","volume":"206","author":"Hobbs","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12931-023-02540-0","article-title":"KIF15 missense variant is associated with the early onset of idiopathic pulmonary fibrosis","volume":"24","author":"Laaka","year":"2023","journal-title":"Respir. Res."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Mohammadi-Nejad, A.-R., Allen, R.J., Kraven, L.M., Leavy, O.C., Jenkins, R.G., Wain, L.V., Auer, D.P., and Sotiropoulos, S.N. (2022). DEMISTIFI Consortium. Mapping brain endophenotypes associated with idiopathic pulmonary fibrosis genetic risk. eBioMedicine, 86.","DOI":"10.1016\/j.ebiom.2022.104356"},{"key":"ref_32","first-page":"210","article-title":"Spanish Guidelines for the Diagnosis and Management of Familial Pulmonary Fibrosis","volume":"58","author":"Cerezales","year":"2022","journal-title":"Arch. Bronconeumol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1164\/rccm.201408-1510OC","article-title":"Rare variants in RTEL1 are associated with familial interstitial pneumonia","volume":"191","author":"Cogan","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1800508","DOI":"10.1183\/13993003.00508-2018","article-title":"Regulator of telomere length 1 (RTEL1) mutations are associated with heterogeneous pulmonary and extra-pulmonary phenotypes","volume":"53","author":"Borie","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Diaz de Leon, A., Cronkhite, J.T., Katzenstein, A.-L.A., Godwin, J.D., Raghu, G., Glazer, C.S., Rosenblatt, R.L., Girod, C.E., Garrity, E.R., and Xing, C. (2010). Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0010680"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1513\/pats.201008-056MS","article-title":"Idiopathic pulmonary fibrosis: Update on genetic discoveries","volume":"8","author":"Garcia","year":"2011","journal-title":"Proc. Am. Thorac. Soc."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1183\/13993003.02115-2015","article-title":"Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis","volume":"48","author":"Borie","year":"2016","journal-title":"Eur. Respir. J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1183\/13993003.00308-2016","article-title":"Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive","volume":"48","author":"Newton","year":"2016","journal-title":"Eur. Respir. J."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Baratella, E., Ruaro, B., Giudici, F., Wade, B., Santagiuliana, M., Salton, F., Confalonieri, P., Simbolo, M., Scarpa, A., and Tollot, S. (2021). Evaluation of Correlations between Genetic Variants and High-Resolution Computed Tomography Patterns in Idiopathic Pulmonary Fibrosis. Diagnostics, 11.","DOI":"10.3390\/diagnostics11050762"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/resp.14195","article-title":"Interstitial lung diseases associated with mutations of poly(A)-specific ribonuclease: A multicentre retrospective study","volume":"27","author":"Philippot","year":"2022","journal-title":"Respirology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"13051","DOI":"10.1073\/pnas.0804280105","article-title":"Short telomeres are a risk factor for idiopathic pulmonary fibrosis","volume":"105","author":"Alder","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.healun.2014.11.010","article-title":"Severe hematologic complications after lung transplantation in patients with telomerase complex mutations","volume":"34","author":"Borie","year":"2015","journal-title":"J. Heart Lung Transplant."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1164\/rccm.200112-123OC","article-title":"Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred","volume":"165","author":"Thomas","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13052-016-0235-x","article-title":"Surfactant Protein C-associated interstitial lung disease; three different phenotypes of the same SFTPC mutation","volume":"42","author":"Salerno","year":"2016","journal-title":"Ital. J. Pediatr."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1183\/09031936.00143610","article-title":"Surfactant protein C G100S mutation causes familial pulmonary fibrosis in Japanese kindred","volume":"38","author":"Ono","year":"2011","journal-title":"Eur. Respir. J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1089\/ped.2010.0004","article-title":"Pathogenesis of Interstitial Lung Disease in Children and Adults","volume":"23","author":"Glasser","year":"2010","journal-title":"Pediatr. Allergy Immunol. Pulmonol."},{"key":"ref_47","first-page":"200085","article-title":"Genetic disorders of the surfactant system: Focus on adult disease","volume":"30","author":"Grutters","year":"2021","journal-title":"Eur. Respir. Rev. Off. J. Eur. Respir. Soc."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2002806","DOI":"10.1183\/13993003.02806-2020","article-title":"Functional assessment and phenotypic heterogeneity of SFTPA1 and SFTPA2 mutations in interstitial lung diseases and lung cancer","volume":"56","author":"Legendre","year":"2020","journal-title":"Eur. Respir. J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/thorax-2022-219434","article-title":"ABCA3-related interstitial lung disease beyond infancy","volume":"78","author":"Li","year":"2023","journal-title":"Thorax"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1465-9921-15-43","article-title":"A large kindred of pulmonary fibrosis associated with a novel ABCA3 gene variant","volume":"15","author":"Campo","year":"2014","journal-title":"Respir. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e70304","DOI":"10.1002\/rcr2.70304","article-title":"ABCA3 Surfactant-Related Gene Variant Associated Interstitial Lung Disease in Adults: A Case Series and Review of the Literature","volume":"13","author":"Nolan","year":"2025","journal-title":"Respirol. Case Rep."},{"key":"ref_52","first-page":"1839","article-title":"Pulmonary Fibrosis in Hermansky-Pudlak Syndrome","volume":"13","author":"Vicary","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/humu.23968","article-title":"Hermansky-Pudlak syndrome: Mutation update","volume":"41","author":"Huizing","year":"2020","journal-title":"Hum. Mutat."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1055\/s-0040-1708088","article-title":"Hermansky\u2013Pudlak Syndrome","volume":"41","author":"Young","year":"2020","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13023-018-0780-z","article-title":"Hermansky-Pudlak syndrome type 2 manifests with fibrosing lung disease early in childhood","volume":"13","author":"Hengst","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Hu, X., Wei, Z., Wu, Y., Zhao, M., Zhou, L., and Lin, Q. (2024). Pathogenesis and Therapy of Hermansky\u2013Pudlak Syndrome (HPS)-Associated Pulmonary Fibrosis. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252011270"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"200193","DOI":"10.1183\/16000617.0193-2020","article-title":"Hermansky-Pudlak syndrome pulmonary fibrosis: A rare inherited interstitial lung disease","volume":"30","author":"Yokoyama","year":"2021","journal-title":"Eur. Respir. Rev."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1164\/rccm.201010-1579PP","article-title":"Epigenetic control of gene expression in the lung","volume":"183","author":"Yang","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1164\/rccm.201201-0077OC","article-title":"Altered DNA methylation profile in idiopathic pulmonary fibrosis","volume":"186","author":"Sanders","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_60","first-page":"1443","article-title":"Competing endogenous RNA networks in pulmonary fibrosis: Regulatory mechanisms and therapeutic potential","volume":"62","author":"Wang","year":"2024","journal-title":"Biochem. Genet."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1515\/med-2021-0231","article-title":"The function of non-coding RNAs in idiopathic pulmonary fibrosis","volume":"16","author":"Zhang","year":"2021","journal-title":"Open Med. (Wars)"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1164\/rccm.200911-1698OC","article-title":"Inhibition and role of let-7d in idiopathic pulmonary fibrosis","volume":"182","author":"Pandit","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.apsb.2016.06.010","article-title":"MicroRNAs in idiopathic pulmonary fibrosis: Involvement in pathogenesis and potential use in diagnosis and therapeutics","volume":"6","author":"Li","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_64","first-page":"223","article-title":"Genetics and environmental interactions in pulmonary fibrosis","volume":"73","author":"Schwartz","year":"2011","journal-title":"Annu. Rev. Physiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1513\/pats.200512-131TK","article-title":"Is idiopathic pulmonary fibrosis an environmental disease?","volume":"3","author":"Taskar","year":"2006","journal-title":"Proc. Am. Thorac. Soc."},{"key":"ref_66","first-page":"1167","article-title":"Toward personalized medicine in idiopathic pulmonary fibrosis","volume":"209","author":"Spagnolo","year":"2024","journal-title":"Am. J. Respir. Crit. Care. Med."},{"key":"ref_67","first-page":"2300897","article-title":"Polygenic risk scores in idiopathic pulmonary fibrosis: A step towards personalized medicine","volume":"62","author":"Oldham","year":"2023","journal-title":"Eur. Respir. J."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1164\/rccm.202212-2257OC","article-title":"A Polygenic Risk Score for Idiopathic Pulmonary Fibrosis and Interstitial Lung Abnormalities","volume":"208","author":"Moll","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1164\/rccm.201506-1063ST","article-title":"An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline","volume":"192","author":"Raghu","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ajhg.2008.11.010","article-title":"Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer","volume":"84","author":"Wang","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"ref_72","first-page":"200035","article-title":"Genetics of pulmonary fibrosis","volume":"29","author":"Newton","year":"2020","journal-title":"Eur. Respir. Rev."},{"key":"ref_73","first-page":"A7633","article-title":"Lung transplantation for telomerase related interstitial lung disease: A single center experience","volume":"201","author":"George","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2003198","DOI":"10.1183\/13993003.03198-2020","article-title":"Safety and Efficacy of Pirfenidone and Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Carrying a Telomere-Related Gene Mutation","volume":"57","author":"Justet","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in Progressive Fibrosing Interstitial Lung Diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1183\/09031936.00060014","article-title":"Lung transplantation in telomerase mutation carriers with pulmonary fibrosis","volume":"44","author":"Silhan","year":"2014","journal-title":"Eur. Respir. J."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1378\/chest.14-0631","article-title":"Short telomeres, telomeropathy, and subclinical extrapulmonary organ damage in patients with interstitial lung disease","volume":"147","author":"George","year":"2015","journal-title":"Chest"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/ajt.16893","article-title":"Determinants of survival after lung transplantation in telomerase-related gene mutation carriers: A retrospective cohort","volume":"22","author":"Mal","year":"2022","journal-title":"Am. J. Transplant."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1164\/rccm.201809-1646OC","article-title":"Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis","volume":"200","author":"Newton","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1056\/NEJM199804303381803","article-title":"Genetic defects and clinical characteristics of patients with a form of oculocutaneous albinism (Hermansky-Pudlak syndrome)","volume":"338","author":"Gahl","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/MCP.0000000000000187","article-title":"Personalized medicine in idiopathic pulmonary fibrosis: Facts and promises","volume":"21","author":"Spagnolo","year":"2015","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Planas-Cerezales, L., Arias-Salgado, E.G., Berastegui, C., Montes-Worboys, A., Gonz\u00e1lez-Montelongo, R., Lorenzo-Salazar, J.M., Vicens-Zygmunt, V., Garcia-Moyano, M., Dorca, J., and Flores, C. (2021). Lung Transplant Improves Survival and Quality of Life Regardless of Telomere Dysfunction. Front. Med., 8.","DOI":"10.3389\/fmed.2021.695919"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1183\/09031936.00163814","article-title":"The genetic basis of idiopathic pulmonary fibrosis","volume":"45","author":"Kropski","year":"2015","journal-title":"Eur. Respir. J."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pharmthera.2015.04.005","article-title":"Idiopathic pulmonary fibrosis: Recent advances on pharmacological therapy","volume":"152","author":"Spagnolo","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12931-020-01339-7","article-title":"A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled \u03b1v\u03b26 integrin inhibitor","volume":"21","author":"Maher","year":"2020","journal-title":"Respir. Res."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Chen, Z., Tang, M., Wang, N., Liu, J., Tan, X., Ma, H., Luo, J., and Xie, K. (2025). Genetic variation reveals the therapeutic potential of BRSK2 in idiopathic pulmonary fibrosis. BMC Med., 23.","DOI":"10.1186\/s12916-025-03848-y"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.tig.2013.06.007","article-title":"Telomerase at the intersection of cancer and aging","volume":"29","author":"Blasco","year":"2013","journal-title":"Trends Genet. TIG"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1056\/NEJMoa1515319","article-title":"Danazol Treatment for Telomere Diseases","volume":"374","author":"Townsley","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e001127","DOI":"10.1136\/bmjresp-2021-001127","article-title":"TELO-SCOPE study: A randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosis","volume":"8","author":"Mackintosh","year":"2021","journal-title":"BMJ Open Respir. Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"10562","DOI":"10.1073\/pnas.1107559108","article-title":"Endoplasmic reticulum stress enhances fibrotic remodeling in the lungs","volume":"108","author":"Lawson","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.matbio.2018.03.015","article-title":"Endoplasmic reticulum stress in pulmonary fibrosis","volume":"68\u201369","author":"Burman","year":"2018","journal-title":"Matrix Biol. J. Int. Soc. Matrix Biol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Tong, B., Fu, L., Hu, B., Zhang, Z.-C., Tan, Z.-X., Li, S.-R., Chen, Y.-H., Zhang, C., Wang, H., and Xu, D.-X. (2021). Tauroursodeoxycholic acid alleviates pulmonary endoplasmic reticulum stress and epithelial-mesenchymal transition in bleomycin-induced lung fibrosis. BMC Pulm. Med., 21.","DOI":"10.1186\/s12890-021-01514-6"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1038\/s41467-018-07768-9","article-title":"Muc5b overexpression causes mucociliary dysfunction and enhances lung fibrosis in mice","volume":"9","author":"Hancock","year":"2018","journal-title":"Nat. Commun."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/24\/11846\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T05:15:34Z","timestamp":1765343734000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/24\/11846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":93,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["ijms262411846"],"URL":"https:\/\/doi.org\/10.3390\/ijms262411846","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]}}}